FDA NDC Directory · JSON-LD · Markdown

Atazanavir

NDC 31722-653 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerCamber Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA212278
Dosage form / routeCAPSULE · ORAL
Active ingredientsATAZANAVIR SULFATE (150 mg/1)
Marketing started20220207
Package count3

External sources

Source: openFDA. Public-domain (CC0).